83 related articles for article (PubMed ID: 25308345)
21. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma.
Lê MG; Arriagada R; Spielmann M; Guinebretière JM; Rochard F
Cancer; 2002 Jun; 94(11):2813-20. PubMed ID: 12115367
[TBL] [Abstract][Full Text] [Related]
22. Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future research.
Bouganim N; Tsvetkova E; Clemons M; Amir E
Breast Cancer Res Treat; 2013 Jun; 139(2):603-6. PubMed ID: 23681402
[TBL] [Abstract][Full Text] [Related]
23. [Locoregional recurrence in breast cancer--what should be done?].
Lütolf UM; Jungi WF
Schweiz Med Wochenschr; 1985 Nov; 115(48):1721-6. PubMed ID: 4081703
[TBL] [Abstract][Full Text] [Related]
24. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Chua DT; Wei WI; Sham JS; Cheng AC; Au G
Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
[TBL] [Abstract][Full Text] [Related]
25. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors affecting the outcome of salvage radiotherapy for isolated locoregional recurrence after mastectomy.
Kim K; Chie EK; Han W; Noh DY; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Am J Clin Oncol; 2010 Feb; 33(1):23-7. PubMed ID: 19704369
[TBL] [Abstract][Full Text] [Related]
27. Management of locoregional recurrence of breast cancer.
Shikama N; Sekiguchi K; Nakamura N
Breast Cancer; 2011 Oct; 18(4):252-8. PubMed ID: 20449777
[TBL] [Abstract][Full Text] [Related]
28. Pitfalls in outcome prediction of breast cancer.
Rakha EA
J Clin Pathol; 2013 Jun; 66(6):458-64. PubMed ID: 23618694
[TBL] [Abstract][Full Text] [Related]
29. Influence of local treatment on the recurrence rate of ductal carcinoma in situ.
Warneke J; Grossklaus D; Davis J; Stea B; Bebb G; Taylor C; Hastings R; Villar H
J Am Coll Surg; 1995 Jun; 180(6):683-8. PubMed ID: 7773481
[TBL] [Abstract][Full Text] [Related]
30. Why does specialist treatment of breast cancer improve survival? The role of surgical management.
Kingsmore D; Hole D; Gillis C
Br J Cancer; 2004 May; 90(10):1920-5. PubMed ID: 15138472
[TBL] [Abstract][Full Text] [Related]
31. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
Skowronek J; Piotrowski T
Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
[TBL] [Abstract][Full Text] [Related]
32. Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research.
Moossdorff M; van Roozendaal LM; Strobbe LJ; Aebi S; Cameron DA; Dixon JM; Giuliano AE; Haffty BG; Hickey BE; Hudis CA; Klimberg VS; Koczwara B; Kühn T; Lippman ME; Lucci A; Piccart M; Smith BD; Tjan-Heijnen VC; van de Velde CJ; Van Zee KJ; Vermorken JB; Viale G; Voogd AC; Wapnir IL; White JR; Smidt ML
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25381395
[TBL] [Abstract][Full Text] [Related]
33. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
Harris EE; Hwang WT; Seyednejad F; Solin LJ
Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
[TBL] [Abstract][Full Text] [Related]
34. Locoregional recurrence after management of carcinoma breast.
Farid G; Rasool MI
J Coll Physicians Surg Pak; 2005 Apr; 15(4):218-20. PubMed ID: 15857594
[TBL] [Abstract][Full Text] [Related]
35. Reirradiation as a component of the multidisciplinary management of locally recurrent breast cancer.
Harkenrider MM; Wilson MR; Dragun AE
Clin Breast Cancer; 2011 Jun; 11(3):171-6. PubMed ID: 21665137
[TBL] [Abstract][Full Text] [Related]
36. Segmental mastectomy and tamoxifen alone provide adequate locoregional control of breast cancer in elderly women.
Yeh S; Tan LR; O'Connell TX
Am Surg; 1997 Oct; 63(10):854-7. PubMed ID: 9322656
[TBL] [Abstract][Full Text] [Related]
37. Who should not undergo breast conservation?
Nijenhuis MV; Rutgers EJ
Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
[TBL] [Abstract][Full Text] [Related]
38. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials.
Punt CJ; Buyse M; Köhne CH; Hohenberger P; Labianca R; Schmoll HJ; Påhlman L; Sobrero A; Douillard JY
J Natl Cancer Inst; 2007 Jul; 99(13):998-1003. PubMed ID: 17596575
[TBL] [Abstract][Full Text] [Related]
39. Statistical grand rounds: design and analysis of studies with binary- event composite endpoints: guidelines for anesthesia research.
Mascha EJ; Sessler DI
Anesth Analg; 2011 Jun; 112(6):1461-71. PubMed ID: 21543784
[TBL] [Abstract][Full Text] [Related]
40. Sample size for studying intermediate endpoints within intervention trails or observational studies.
Freedman LS; Schatzkin A
Am J Epidemiol; 1992 Nov; 136(9):1148-59. PubMed ID: 1462974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
